Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H van Gilst

Showing results (1-10 of 211) with videos related to

Pageof 22
Sort By:
Journal of Cardiovascular Pharmacology|January 1, 1989
Protection of the myocardium against postischemic reperfusion damageW H van Gilst
European Heart Journal|April 1, 1996
Calcium antagonism in perspective: new data on diltiazem in unstable anginaW H van Gilst, K I Lie
Circulation|March 1, 1995
Beta-adrenergic blockade and heart rateY S Tuininga, W H van Gilst
Cardiovascular Research|October 28, 1999
The ACE gene polymorphism: the good, the bad and the uglyY M Pinto, W H van Gilst
Herz|December 1, 1993
Angiotensin-converting enzyme inhibition during thrombolytic therapy in acute myocardial infarction: the Captopril and Thrombolysis Study (CATS)J H Kingma, W H van Gilst
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Unexpected news from the scientific sessions of the American College of CardiologyA A Voors, W H van Gilst
The American Journal of Cardiology|November 18, 1991
Early intervention with angiotensin-converting enzyme inhibitors during thrombolytic therapy in acute myocardial infarction: rationale and design of captopril and thrombolysis study. CATS investigators groupW H van Gilst, J H Kingma
Basic Research in Cardiology|May 1, 1987
Calcium repletion-induced arrhythmias after short periods of calcium-free perfusion in the isolated rat heartW H van Gilst, J M Koomen
Agents and Actions. Supplements|January 1, 1992
The effect of bradykinin on coronary flow and its potentiation by SH-containing ACE-inhibitorsP A de Graeff, W H van Gilst
Lancet (London, England)|November 18, 2000
Vasopeptidase inhibition in heart failureD J van Veldhuisen, W H van Gilst
Pageof 22

Showing results (1-10 of 211) with videos related to

Sort By:
Pageof 22
Journal of Cardiovascular Pharmacology|January 1, 1989
Protection of the myocardium against postischemic reperfusion damageW H van Gilst
European Heart Journal|April 1, 1996
Calcium antagonism in perspective: new data on diltiazem in unstable anginaW H van Gilst, K I Lie
Circulation|March 1, 1995
Beta-adrenergic blockade and heart rateY S Tuininga, W H van Gilst
Cardiovascular Research|October 28, 1999
The ACE gene polymorphism: the good, the bad and the uglyY M Pinto, W H van Gilst
Herz|December 1, 1993
Angiotensin-converting enzyme inhibition during thrombolytic therapy in acute myocardial infarction: the Captopril and Thrombolysis Study (CATS)J H Kingma, W H van Gilst
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Unexpected news from the scientific sessions of the American College of CardiologyA A Voors, W H van Gilst
The American Journal of Cardiology|November 18, 1991
Early intervention with angiotensin-converting enzyme inhibitors during thrombolytic therapy in acute myocardial infarction: rationale and design of captopril and thrombolysis study. CATS investigators groupW H van Gilst, J H Kingma
Basic Research in Cardiology|May 1, 1987
Calcium repletion-induced arrhythmias after short periods of calcium-free perfusion in the isolated rat heartW H van Gilst, J M Koomen
Agents and Actions. Supplements|January 1, 1992
The effect of bradykinin on coronary flow and its potentiation by SH-containing ACE-inhibitorsP A de Graeff, W H van Gilst
Lancet (London, England)|November 18, 2000
Vasopeptidase inhibition in heart failureD J van Veldhuisen, W H van Gilst
Pageof 22